Fresh2 Group Limited
NASDAQ: FRES0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Haohan Xu
- Employees
- 75
- Headquarters
- New York City, United States
- IPO year
- 2020
- Market cap
- $2.1M
- Website
- https://fresh2.co
Loading FRES…
Loading profile data…Frequently asked questions about FRES
What does Fresh2 Group Limited (FRES) do?
Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests...
Where does FRES trade?
Fresh2 Group Limited (FRES) trades on the NASDAQ Capital Market.
What sector is FRES in?
Fresh2 Group Limited (FRES) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Fresh2 Group Limited?
Haohan Xu is the chief executive officer of Fresh2 Group Limited (FRES).
Where is Fresh2 Group Limited headquartered?
Fresh2 Group Limited is headquartered in United States.
Does FRES pay a dividend?
Fresh2 Group Limited (FRES) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FRES go public?
Fresh2 Group Limited (FRES) completed its initial public offering in 2020.
Is FRES an ADR?
Yes — FRES is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Fresh2 Group Limited reporting and dividends follow the underlying issuer.